for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Basilea FY 2019 Total Revenue Expected To Increase To About CHF 134 Mln

Jan 10 (Reuters) - BASILEA PHARMACEUTICA AG:

* BASILEA REPORTS TOTAL REVENUE EXCEEDING GUIDANCE DRIVEN BY HIGHER THAN EXPECTED CONTRIBUTIONS FROM CRESEMBA® AND ZEVTERA® IN 2019

* FY TOTAL REVENUE IS EXPECTED TO INCREASE TO APPROX. CHF 134 MILLION (FYR 2018: CHF 132.6 MILLION) Source text for Eikon: Further company coverage: (Gdansk Newsroom)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up